FDA approves Xeljanz for rheumatoid arthritis
On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis who…
Technology
Advancing adoption of the electronic health record
Experts at the federal level are working to actualize the promise of health information technology.
Pharmacology review: Drugs that alter blood coagulation
Brush up on your knowledge of these potentially life-saving drugs.
Understanding end-tidal CO2 monitoring
This noninvasive technique gives early warning of respiratory compromise.
FDA approves Synribo for chronic myelogenous leukemia
On Oct. 26, the U.S. Food and Drug Administration (FDA) approved Synribo (omacetaxine mepesuccinate) for the treatment of adults with chronic myelogenous leukemia. Synribo…
Quiz Time
A goal of the induction phase of therapeutic hypothermia after cardiac arrest is to: a. quickly warm the patient to target body temperature. b.…
New report on how mobile devices are transforming health care
May’s Issues in Technology Innovation includes the report “How Mobile Devices are Transforming Healthcare,” which includes a review of techniques for managing patients with…
Recent advances in cardiac diagnostic and surgical procedures
New techniques expand the options for high-risk patients and cause fewer complications than conventional surgery.
FDA approves new drug for irritable bowel syndrome and constipation
On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome…
FDA approves Marqibo for rare type of leukemia
On Aug. 9, the U.S. Food and Drug Administration (FDA) approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome negative (Ph-)…
IOM releases report on accelerating new drug and diagnostics development
On Aug. 22, the Institute of Medicine released “Accelerating the development of new drugs and diagnostics: Maximizing the impact of the Cures Acceleration Network—Workshop…
Using evidence-based practice to develop a swallow screen for stroke patients
The author takes the reader on her step-by-step journey that resulted in a change in practice.
FDA approves Xeljanz for rheumatoid arthritis
On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid…
Advancing adoption of the electronic health record
Experts at the federal level are working to actualize the promise of health information technology.
Pharmacology review: Drugs that alter blood coagulation
Brush up on your knowledge of these potentially life-saving drugs.
Understanding end-tidal CO2 monitoring
This noninvasive technique gives early warning of respiratory compromise.
FDA approves Synribo for chronic myelogenous leukemia
On Oct. 26, the U.S. Food and Drug Administration (FDA) approved Synribo (omacetaxine mepesuccinate) for the treatment of adults with chronic myelogenous…
Quiz Time
A goal of the induction phase of therapeutic hypothermia after cardiac arrest is to: a. quickly warm the patient to target body…
New report on how mobile devices are transforming health care
May’s Issues in Technology Innovation includes the report “How Mobile Devices are Transforming Healthcare,” which includes a review of techniques for managing…
Recent advances in cardiac diagnostic and surgical procedures
New techniques expand the options for high-risk patients and cause fewer complications than conventional surgery.
FDA approves new drug for irritable bowel syndrome and constipation
On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable…
FDA approves Marqibo for rare type of leukemia
On Aug. 9, the U.S. Food and Drug Administration (FDA) approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome…
IOM releases report on accelerating new drug and diagnostics development
On Aug. 22, the Institute of Medicine released “Accelerating the development of new drugs and diagnostics: Maximizing the impact of the Cures…
Using evidence-based practice to develop a swallow screen for stroke patients
The author takes the reader on her step-by-step journey that resulted in a change in practice.
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.